How to Help Your Patients Find Eletriptan in Stock: A Provider's Guide

Prescribing eletriptan is the first step. The second — and often more challenging — step is ensuring your patient actually gets it. Insurance quantity limits, step therapy requirements, and pharmacy stocking variability can all stand between a prescription and a filled prescription. This guide provides a practical, workflow-oriented approach to helping your patients navigate each barrier.

Step 1: Set Expectations at the Point of Prescribing

Before your patient leaves the office or telehealth session, proactively discuss:

Their insurance plan's quantity limit for triptans (typically 4–9/month; eletriptan is often on the lower end)

The possibility of prior authorization if they haven't trialed sumatriptan first

That GoodRx can reduce the cost of generic eletriptan to as low as $21–$25 for 6 tablets — useful for filling additional quantities beyond the insurance limit

That medfinder can help them locate which pharmacies near them have eletriptan in stock

Step 2: Write the Prescription Strategically

A few prescription-writing practices improve the chances of a successful fill:

Prescribe generic, not brand. Generic eletriptan is widely available and dramatically cheaper. Prescribing brand-name Relpax by DAW (Dispense as Written) will result in higher cost and may trigger formulary rejection.

Write for the clinically appropriate quantity. Write the prescription for 9–12 tablets/month even if insurance only covers 4–6. The patient can fill the insurance-covered portion and self-pay (with a discount coupon) for the rest. This requires two separate fill transactions at the pharmacy.

Include explicit indication. Adding "for acute migraine" to the prescription note can help pharmacists process the claim correctly and flag if an alternative is being substituted inappropriately.

Step 3: Be Ready to Submit a Prior Authorization Quickly

If a patient's insurance requires step therapy and the claim is rejected, your office will likely receive a PA request. To get it approved quickly:

Document the names, doses, and duration of prior triptan trials in the chart

Note specific reasons for failure: inadequate efficacy, intolerable side effects, or contraindications

Include migraine frequency (days per month) and impact on functioning to justify medical necessity for higher-than-limit quantities

Submit the PA within 24–48 hours of the rejection to avoid extended delays; for urgent cases, many payers have expedited review pathways

Step 4: Direct Patients to Pharmacy-Finding Tools

If a patient calls your office reporting that their pharmacy doesn't have eletriptan in stock, direct them to medfinder. medfinder calls pharmacies near the patient's location to find which ones currently have the medication in stock, then texts the patient the results. This reduces calls to your office and helps patients resolve access issues without needing a new prescription.

You can also advise patients to ask their pharmacy about special orders if no location currently stocks the medication. Most pharmacies can fulfill a special order for eletriptan within 24–48 hours through their wholesaler.

Step 5: Have a Backup Prescription Ready

For patients with frequent migraines and known access challenges, consider co-prescribing a second triptan as a backup. Sumatriptan 50 mg or 100 mg tablets are the most logical choice — broadly available, inexpensive, and familiar to most pharmacists. This way, if eletriptan is temporarily unavailable at a particular pharmacy, the patient isn't left without treatment.

Step 6: Address Medication Overuse Headache Risk

Patients using triptans on ≥10 days per month are at risk for medication overuse headache (MOH). This is worth monitoring and discussing. Patients who are consistently hitting their triptan limits are often the best candidates for preventive therapy — CGRP monoclonal antibodies, topiramate, valproate, or amitriptyline — which can reduce monthly attack frequency and decrease acute medication burden.

For more tools and resources for providers navigating medication access challenges, visit medfinder for providers.